Sitagliptin phosphate and dapagliflozin"""

Sitagliptin phosphate and dapagliflozin
ST- Gliptin Dapa 100/10 are two medications commonly used in the management of type 2 diabetes. They belong to different classes of antidiabetic drugs and work in different ways to help control blood sugar levels.
Sitagliptin phosphate: Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by inhibiting the enzyme DPP-4, which breaks down incretin hormones such as glucagon-like peptide-1 (GLP-1). By inhibiting DPP-4, sitagliptin increases the levels of active GLP-1 in the body. GLP-1 helps stimulate insulin secretion, decrease glucagon production (which increases blood sugar), and reduce the rate at which glucose is released from the liver. Sitagliptin is usually taken orally once a day.
Dapagliflozin: Dapagliflozin is a sodium-glucose co-transporter-2 (SGLT2) inhibitor. It works by inhibiting the SGLT2 protein in the kidneys, which is responsible for reabsorbing glucose back into the bloodstream. By inhibiting SGLT2, dapagliflozin allows excess glucose to be excreted through the urine, thereby reducing blood sugar levels. Dapagliflozin also promotes mild weight loss and can have a positive impact on blood pressure. It is usually taken orally once a day.
ST- Gliptin Dapa 100/10  are often used in combination with other antidiabetic medications or as part of a comprehensive treatment plan for type 2 diabetes. ST- Gliptin Dapa 100/10   combination of these two medications can provide complementary mechanisms of action to help control blood sugar levels.
For further information please contact:
info@sterispharma.com
Order NOW - https://www.sterisonline.com/product/st-gliptin-dapa-100-10-134075